ViewRay® Newsroom

ViewRay® to Host Analyst & Investor Meeting at ASTRO in San Diego

September 20, 2017

CLEVELAND, September 20, 2017 — ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for analysts and investors on Monday, September 25, 2017, during the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego. 

The meeting will include breakfast, a company update from ViewRay management, and a presentation from M Salim U Siddiqui, MD, PhD, Department of Radiation Oncology at Henry Ford Cancer Institute. Dr. Siddiqui will discuss clinical experiences at Henry Ford Cancer Center with the world’s first FDA-Cleared MRI guided linear accelerated-based radiation therapy system.

Event: ViewRay Analyst & Investor Meeting
Date: Monday, September 25, 2017
Time: 7:00 – 8:30 a.m. PT
Location: Marriott Marquis, 333 W Harbor Dr. San Diego, CA, South Tower, Level 3

An audio webcast of the presentation will be available on the investor relations section of ViewRay’s website at www.viewray.com. A replay of the webcast will be available for 90 days after the date of the presentation.

To attend the live event, please RSVP to Brian Johnston at bjohnston@theruthgroup.com.

About ViewRay

ViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.

ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Contact:
Michael Saracen
Vice President, Marketing
ViewRay, Inc.
Phone: +1 408-242-2994
Email: media@viewray.com

 


Copyright 2017 © ViewRay. All rights reserved - KMCreative